Trump’s latest tariff plan aims at multiple countries. What does it mean for the US?
As dozens of hair salons open in Geylang, some offer more than just a haircut
Vail Resorts Reports Fiscal 2025 First Quarter and Season Pass Sales Results, and Announces 2025 Capital PlanPRINCETON, NJ, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the "Company" or "Sonnet") (NASDAQ:SONN), a clinical-stage company developing targeted immunotherapeutic drugs, announced today that it has entered into a definitive agreement with institutional investors for the purchase and sale of an aggregate of 1,085,325 shares of its common stock (or common stock equivalents in lieu thereof) (the “Registered Direct Shares”) and warrants to purchase up to an aggregate of 1,085,325 shares of common stock (the “Registered Direct Warrants”), in a registered direct offering. Each share of common stock (or pre-funded warrant in lieu thereof) is being sold in the registered direct offering together with one common warrant at a combined offering price of $2.23, priced at-the-market under the rules of the Nasdaq Stock Market. The Registered Direct Warrants will have an exercise price of $2.10 per share, are immediately exercisable and will expire five years from the date of issuance. The Company has also entered into a definitive agreement with an existing investor, in a concurrent private placement, for the purchase and sale of an aggregate of 673,000 shares of its common stock (or common stock equivalents in lieu thereof) (the “PIPE Shares”) and warrants to purchase up to an aggregate of 673,000 shares of common stock (the “PIPE Warrants”). Each share of common stock (or pre-funded warrant in lieu thereof) is being sold in the private placement offering together with one common warrant at a combined offering price of $2.23, priced at-the-market under the rules of the Nasdaq Stock Market. The PIPE Warrants will have an exercise price of $2.10 per share, are immediately exercisable and will expire five years from the date of issuance. The closing of the registered direct offering and the concurrent private placement is expected to occur on or about December 10, 2024, subject to the satisfaction of customary closing conditions. Chardan is acting as the exclusive placement agent for the registered direct offering and the concurrent private placement. The gross proceeds to the Company from the registered direct offering and the concurrent private placement are expected to be approximately $3.9 million, before deducting the placement agent's fees and other offering expenses payable by the Company. The Company intends to use the net proceeds for research and development, including clinical trials, working capital and general corporate purposes. The Registered Direct Shares are being offered and sold by the Company in a registered direct offering pursuant to a "shelf" registration statement on Form S-3 (File No. 333-251406) that was originally filed with the Securities and Exchange Commission (the "SEC") on December 22, 2023, and declared effective on January 4, 2024. The offering of such securities in the registered direct offering is being made only by means of a prospectus supplement that forms a part of the effective registration statement. A final prospectus supplement and the accompanying base prospectus relating to the registered direct offering will be filed with the SEC and will be available on the SEC's website at www.sec.gov . Electronic copies of the final prospectus supplement and the accompanying base prospectus may also be obtained, when available, from Chardan Capital Markets, LLC, 17 State Street, Suite 2130, New York, New York 10004, at (646) 465-9000, or by email at vdealwis@chardan.com . The PIPE Shares, the PIPE Warrants and the Registered Direct Warrants and the shares underlying the PIPE Warrants and the Registered Direct Warrants described above are being offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Act"), and Regulation D promulgated thereunder and have not been registered under the Act, or applicable state securities laws. Accordingly, the PIPE Shares, the PIPE Warrants, the Registered Direct Warrants and the shares of common stock underlying the PIPE Warrants and the Registered Direct Warrants may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Act and such applicable state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. About Sonnet BioTherapeutics Holdings, Inc. Sonnet is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bifunctional action. Known as F H AB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and "hitch-hikes" on human serum albumin (HSA) for transport to target tissues. Sonnet's F H AB was designed to specifically target tumor and lymphatic tissue, with an improved therapeutic window for optimizing the safety and efficacy of immune modulating biologic drugs. F H AB is the foundation of a modular, plug-and-play construct for potentiating a range of large molecule therapeutic classes, including cytokines, peptides, antibodies, and vaccines. Forward-Looking Statements This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and Private Securities Litigation Reform Act, as amended, including those relating to the closing of the registered direct offering and the concurrent private placement and the expected use of proceeds, the outcome of the Company’s clinical trials, the Company's cash runway, the Company's product development, clinical and regulatory timelines, market opportunity, competitive position, possible or assumed future results of operations, business strategies, potential growth opportunities and other statements that are predictive in nature. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which we operate and management's current beliefs and assumptions. These statements may be identified by the use of forward-looking expressions, including, but not limited to, "expect," "anticipate," "intend," "plan," "believe," "estimate," "potential,” "predict," "project," "should," "would" and similar expressions and the negatives of those terms. These statements relate to future events or our financial performance and involve known and unknown risks, uncertainties, and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include those set forth in the Company's filings with the Securities and Exchange Commission. Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Investor Relations Contact: JTC Team, LLC Jenene Thomas 908.824.0775 SONN@jtcir.com Source: Sonnet BioTherapeutics Holdings, Inc.
GREENSBORO, N.C. (AP) — Matthew Downing threw for two touchdowns and ran for another to lead Elon to a 31-21 season-ending win over North Carolina A&T on Saturday. The game was tied at 7 in the second quarter when the Phoenix turned a fumble recovery into a field goal. That started a string of four-straight scoring possessions. Downing was 16 of 21 for 203 yards. Chandler Brayboy had 12 receptions for 118 yards with a score. Rushawn Baker ran for 106 yards for the Phoenix (6-6, 5-3 Coastal Athletic Association). Julian Bumper also had a 10-yard rushing touchdown on his only carry and Jamarien Dalton had a 30-yard receiving touchdown on his only catch. Freshman Cortez Lane returned a kickoff 97 yards for a touchdown for the Aggies (1-11, 0-8), who lost their 11th straight. Justin Fomby threw for 190 yards and a touchdown pass to Daniel Cole and Shimique Blizzard ran for 87 yards and a TD. AP college football: https://apnews.com/hub/ap-top-25-college-football-poll and https://apnews.com/hub/college-football . Sign up for the AP’s college football newsletter: https://apnews.com/cfbtop25
Saudi Aramco stages major comeback in Philippine energy sector: Unioil in sight?
Empowered Funds LLC Acquires 1,474 Shares of Rocky Brands, Inc. (NASDAQ:RCKY)
A Michigan man now has a college fund for his children thanks to work by Iowa Treasurer Roby Smith and State Rep. Mike Vondran, who helped reunite him with more than $317,000 in lost property. Smith and Vondran marked the found funds with an event at the Scott County Treasurer's Office Tuesday morning. The connection was made as part of the Great Iowa Treasure Hunt. Each year, millions of dollars are turned over to the state treasurer for safekeeping after financial institutions and businesses lose contact with the owner. Every effort is made to return the assets back to the rightful owner or their heirs. Examples include dormant checking and savings accounts, uncashed checks, lost stocks and bonds, utility security refunds and insurance benefits, according to a news release. Smith said he gave Vondran a list of the top 100 people in his district with unclaimed property. This was by far the largest amount, Vondran said. "Mine range from a low of $12,000 to a high of $317,000. It's an amazing thing when you find these resources, these legacies have just kind of disappeared on people and they wind up here," Vondran said. "These dollars have to go somewhere, by law, so they wind up in this account, and many people just lose track of things." The check presented on Tuesday was a result of a family member passing and their assets getting lost in the process, he said. "This individual's legacy was sitting in the account without an attachment to family and heirs, and we were able to find the single heir," he said. But, there was a catch. When Vondran called the heir — a man named Robert who resides in Michigan — Robert thought it was all a lie. "(Robert) actually called me one day out of the blue, after me leaving repeated messages, and said, 'Hey, I'm so sorry. I thought it was a scam. I was actually traveling through the Quad-Cities ... visiting with family, and referenced this and said, 'You can't believe what just happened to me,''" Vondran recounted. "And his distant cousin said, 'Well, I know Mike. He's my representative.' And then we called and made the connection." Vondran sent over the proper paperwork and in less than two weeks, Robert, who was not present Tuesday, was united with the lost family money, which he plans to use for his children's college fund, Vondran said. "It's a great story, and it's one of the largest (returns) in the history of Scott County," Smith said. "We gave out a record number last year, almost $35 million was the record in the history of Iowa, that we've given back. And the top amount was around the $4 million but I can tell you, as part of the history, this is up there for Scott County." The state has more than $566 million it is looking to return to its rightful owners, Smith said. Anyone who would like to search for a claim can go to and type in their information. Get the latest local business news delivered FREE to your inbox weekly.
Amaravati: Andhra Pradesh Chief Minister N Chandrababu Naidu on Saturday congratulated the BJP-led Mahayuti Alliance on securing a historic mandate in Maharashtra. In a post on X, Naidu said the imminent victory reflects people’s continued trust in the leadership of Prime Minister Narendra Modi whose strategic vision, and policies are paving the way for a “Viksit Bharat” to emerge. “Congratulations to the Mahayuti Alliance on securing a historic mandate in Maharashtra. This victory reflects people’s continued trust in the leadership of the Hon’ble Prime Minister Shri @narendramodi Ji, whose strategic vision, transformative policies and devotion to the people are paving the way for a Viksit Bharat to emerge,” Naidu said. Congratulations to the Mahayuti Alliance on securing a historic mandate in Maharashtra. This victory reflects people's continued trust in the leadership of the Hon'ble Prime Minister Shri @narendramodi Ji, whose strategic vision, transformative policies and devotion to the people... pic.twitter.com/u40WTplSyh Meanwhile, AP BJP chief D Purandeswari in a post greeted all the party karyakartas, leaders, and people of Maharashtra over the victory. “The people of Maharashtra have sent a clear message against the divisive politics of Congress,” the BJP leader said. The poll outcome reflects a rejection of the INDI Alliance’s mindset, and shows that the BJP’s vision, as articulated by PM Modi, resonates with the people. “Together, we are paving the way for Maharashtra’s development,” she added. As per the latest counting trends, Mahayuti Alliance is heading towards a landslide victory in Maharashtra.Vail Resorts Reports Fiscal 2025 First Quarter and Season Pass Sales Results, and Announces 2025 Capital Plan
Elon's STATUS RISES with electionThe Verdict Is in — ‘Juror No. 2’ Is #1 on VOD While ‘Red One’ and ‘Conclave’ Get Warp Speed Streaming
TOLEDO, Ohio (AP) — Sam Lewis' 18 points helped Toledo defeat Defiance 111-49 on Saturday. Lewis also had five rebounds for the Rockets (6-3). Javan Simmons scored 16 points while shooting 8 of 9 from the field and 0 for 3 from the line and added eight rebounds. Sonny Wilson finished 7 of 10 from the field to finish with 16 points. Jalen Brown finished with 12 points for the Yellow Jackets. Connor Bush added eight points for Defiance. Donovan Stone finished with eight points. Toledo took the lead with 19:42 remaining in the first half and did not relinquish it. The score was 55-23 at halftime, with Simmons racking up 14 points. Toledo extended its lead to 90-34 during the second half, fueled by a 16-3 scoring run. Grgur Brcic scored a team-high 10 points in the second half as their team closed out the win. The Associated Press created this story using technology provided by Data Skrive and data from Sportradar .
California researchers say the world may be just one genetic tweak away from human-to-human transmission of the H5N1 bird flu virus — a worrisome mutation that could open the door to widespread human infections and possibly even a pandemic, according to some experts. In a study published Thursday in the journal Science, Scripps Research Institute biologists determined that a single mutation of the hemagglutinin protein — the “H” in H5N1 — could transform a virus that has so far sickened or killed mostly birds and cows into a pathogen that targets cells in human beings. The finding comes amid a growing number of H5N1 outbreaks among California dairy cows, as well as a state-ordered recall of raw milk products . Since the virus began infecting the nation’s dairy stock in March, infectious disease experts have warned that unprotected contact between dairy workers and infected cows could enable the virus to evolve in a manner that threatens humans. Now, Scripps researchers suggest the path for such a genetic change may be much shorter than state and national health officers anticipated. “This really surprised us,” said study coauthor James Paulson, a biochemist and molecular biologist. This one mutation “satisfies a requirement for transmission,” he said. Richard Webby, director of the World Health Organization’s Collaborating Center for Studies on the Ecology of Influenza in Animals and Birds, said the study’s finding countered prevailing thought on the virus — specifically, that it would take multiple mutations for the virus to pose a threat to humans. “This will likely cause a stir,” said Webby, who is also a researcher in the department of infectious diseases at St. Jude Children’s Research Hospital in Memphis, Tenn., and was not involved in the Scripps research. “I think most of us thought it would probably need more than one change,” Webby said. Yoshihiro Kawaoka, a virologist at the University of Wisconsin-Madison and the University of Tokyo, called the Scripps teams’ finding a “significant discovery” and said it was “critical because, given the mutation rate of influenza viruses, one in every 10,000 particles of the bovine H5N1 virus could carry this mutation.” That means the potential emergence of an H5N1 virus “that can recognize human receptors is closer than we may have thought,” he said. Several months ago, Paulson and coauthor Ian Wilson, a Scripps structural biologist, decided they’d investigate the current H5N1 strain, and see what it would take for it to cause a human pandemic. Paulson is an expert in researching where and how different influenza viruses bind to cells when they enter a host. Wilson studies the structure of influenza virus proteins. The scientists began their research by accessing a global influenza database and locating the genetic sequence for A/Texas/37/2024 — the strain of H5N1 bird flu found in a Texas dairy worker. They then examined the hemagglutinin proteins, or spikes, on the outer surface of the virus, since those enable it to latch onto the cell membrane of its host. Animals such as birds and humans have different docking stations on their cells — known as sialic acid receptors. In order for a flu virus to open a door into a cell and begin replicating, it needs just the right spike, or key. Although more than 50 humans have been infected by H5N1, many of these cases involve dairy workers who were likely sprayed in the eyes and nose with milk from infected cows. Researchers postulate that repeated exposure of this sort allowed the virus to push into the cells — a brute force entry more than a lock-picking. Ordinarily, person-to-person transmission of a flu virus “is mainly through the air from droplets from a sneeze or cough, which contains very little virus,” Paulson said. “In this context, the virus needs to be able to recognize human-type receptors to bind to cells in the human airway in amounts sufficient to cause infection.” In order to figure out what it would take for the virus to gain the right docking equipment to unleash a human pandemic, Paulson, Wilson and their team looked at previous flu outbreaks that had jumped the bird-human divide, including the influenza outbreaks of 1918, 1957, 1968 and 2009 — as well as some earlier research. They “selected a number of positions” on the hemagglutinin protein “to mutate, one at a time” with amino acids they knew had been implicated in previous pandemics. Then they attempted to bind these altered “H” proteins with human and bird receptor analogues. Lo and behold, when they switched a glutamine to a leucine at position 226, it no longer bound to the bird receptors, but instead exclusively to those of humans. Paulson said it was especially interesting because this mutation had occurred before in earlier strains of H5N1, including one from around 2010 — but “at that time, that single mutation was not sufficient to change receptor specificity. So, the unexpected thing is that virus has changed in subtle ways — evolved, if you will — so that now that single mutation does change the receptor specificity.” Although the researchers demonstrated that it was possible for the virus to become a threat to humans with just one genetic change, that does not mean nature will follow that specific path. A multitude of factors can influence the evolution of an organism, and they are not easily predicted. This may be why the virus has not yet gained the ability to widely infect humans, some say. “Despite more than 50 human infections with bovine H5N1, we have not seen evidence of this virus adapting to humans on a larger scale,” Kawaoka said. “This suggests that ... additional mutations are likely required for the virus to become fully transmissible between humans.” Paulson acknowledged that the “context of the total biological picture is extremely important.” He said the research focused on just “one property that is important for the virus to be successful when adapting to a new host,” but there are others that may also be important. For instance, H5N1 in the past was known to cause severe respiratory disease. But recently, it’s mostly been associated with conjunctivitis and only occasionally with mild, upper respiratory disease in people. “Why is that? I don’t think anybody knows,” Paulson said. What is known is that the virus is moving swiftly through a variety of species around the globe — with ample opportunity to mutate and adapt. As of Thursday, the Centers for Disease Control and Prevention had confirmed H5N1 infections in 58 people: 35 as a result of working with infected dairy cows, 21 from infected poultry, and in two cases, the source is unknown. In addition, 707 dairy herds across 15 states have also been infected. And in just the last 30 days, 23 commercial poultry farms in California have come down with the virus — affecting more than 5.6 million birds. _____ ©2024 Los Angeles Times. Visit at latimes.com . Distributed by Tribune Content Agency, LLC.Middle East latest: Syria's forces withdraw from Homs, a key link between the capital and coast
Swiss National Bank Has $16.99 Million Stock Holdings in Lithia Motors, Inc. (NYSE:LAD)From the Publisher | The Role of a TeacherSKOPJE, North Macedonia (AP) — A political party in North Macedonia on Saturday demanded authorities ban social networks whose content incites violence and self-destructive behavior after several young people were seriously injured in connection with the popular “Superman challenge” on TikTok. Health authorities said at least 17 students, ages 10 to 17, were brought to hospitals in the capital Skopje and other towns over the past week with broken bones, contusions and bruises. The children were injured after being thrown into the air by their friends to fly like superheroes and get applause on the internet. The Liberal-Democratic Party, which was part of the left-led coalition that ruled the country from 2016 to earlier in 2024, issued a press statement Saturday strongly condemning “the irresponsible spread of dangerous content on social media, such as the latest TikTok ‘challenge’ known as ‘Superman,’ which has injured six children across (the country) in the past 24 hours.” “The lack of adequate control over the content of social media allows such ‘games’ to reach the most vulnerable users,” the party statement said. It demanded the “immediate introduction of measures to ban content that incites violence and self-destructive behavior, increase surveillance, and sanction platforms that enable dangerous trends.” North Macedonia’s education minister Vesna Janevska said students should focus on education, not TikTok challenges. “The ban on mobile phones in schools will not have an effect. Phones will be available to children in their homes, neighborhoods and other environments,” she said. Psychologists have warned that the desire to be “in” with the trends on social networks, combined with excessive use of mobile phones, is the main reason for the rise in risky behaviors among children. They urged parents and schools to talk with students.
Geneva, Switzerland , Dec. 16, 2024 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum technology hardware and software products, today announced that it has entered into a securities purchase agreement with several institutional investors to purchase 13,157,896 ordinary shares at a public offering price of $1.90, for gross proceeds of $25.0 million (the “Offering”), before deducting commissions and offering expenses. Maxim Group LLC is acting as the sole placement agent for the Offering. SEALSQ currently intends to utilize the net proceeds from the Offering to fund the deployment of its next-generation post-quantum semiconductor technology and ASIC capabilities in the United States, to support working capital and for general corporate purposes. The Offering is expected to close on or about December 17, 2024 (the “Closing Date”), subject to the satisfaction of customary closing conditions. The Offering is being made pursuant to an effective shelf registration statement on Form F-3 (File No. 333-283358) previously filed with and subsequently declared effective by the U.S. Securities and Exchange Commission (“SEC”) on November 27, 2024. A prospectus supplement relating to the securities to be issued in the Offering will be filed by the Company with the SEC. When available, copies of the prospectus supplement relating to the Offering, together with the accompanying prospectus, can be obtained at the SEC's website at www.sec.gov or by contacting Maxim Group LLC, at 300 Park Avenue, 16th Floor, New York, NY 10022, Attention: Syndicate Department, or via email at syndicate@maximgrp.com or by telephone at (212) 895-3745. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. About SEALSQ: SEALSQ focuses on selling integrated solutions based on Semiconductors, PKI and Provisioning services, while developing Post-Quantum technology hardware and software products. Our solutions can be used in a variety of applications, from Multi-Factor Authentication tokens, Smart Energy, Smart Home Appliances, Medical and Healthcare and IT Network Infrastructure, to Automotive, Industrial Automation and Control Systems. Post-Quantum Cryptography (PQC) refers to cryptographic methods that are secure against an attack by a quantum computer. As quantum computers become more powerful, they may be able to break many of the cryptographic methods that are currently used to protect sensitive information, such as RSA and Elliptic Curve Cryptography (ECC). PQC aims to develop new cryptographic methods that are secure against quantum attacks. For more information, please visit www.sealsq.com. Forward Looking Statements This communication expressly or implicitly contains certain forward-looking statements concerning SEALSQ Corp and its businesses. Forward-looking statements include statements regarding our business strategy, financial performance, results of operations, market data, events or developments that we expect or anticipates will occur in the future, as well as any other statements which are not historical facts. Although we believe that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct. These statements involve known and unknown risks and are based upon a number of assumptions and estimates which are inherently subject to significant uncertainties and contingencies, many of which are beyond our control. Actual results may differ materially from those expressed or implied by such forward-looking statements. Important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include SEALSQ’s ability to implement its growth strategies; SEALSQ’s ability to successfully launch post-quantum semiconductor technology; SEALSQ’s ability to capture a share of the quantum semiconductor market; the growth of the quantum computing market; SEALSQ’s ability to expand its U.S. operations; SEALSQ’s ability to make additional investments towards the development of a new generation of quantum-ready semiconductors; SEALSQ’s ability to continue beneficial transactions with material parties, including a limited number of significant customers; market demand and semiconductor industry conditions; the growth of the quantum computing market; and the risks discussed in SEALSQ’s filings with the SEC. Risks and uncertainties are further described in reports filed by SEALSQ with the SEC. SEALSQ Corp is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise. Press and Investor Contacts SEALSQ Corp. Carlos Moreira Chairman & CEO Tel: +41 22 594 3000 info@sealsq.com SEALSQ Investor Relations (US) The Equity Group Inc. Lena Cati Tel: +1 212 836-9611 / lcati@equityny.com Katie Murphy Tel: +212 836-9612 / kmurphy@equityny.com